info@allievapharma.com

  • 24/7
    Customer Service
  • ISO 9001
    Certification Company
  • WHO-GMP
    Certified Company
OUR CATALOGUE OUR CATALOGUE

    • Lung Cancer

    Lung Cancer Products

    Discover a wide range of Lung Cancer products under the Oncology category. Allieva Pharma provides high-quality pharmaceutical solutions trusted across India and global markets.

    ERLOLIEVA 150MG Erlotinib Tablets IP 150mg by ERLOLIEVA 150MG

    ERLOLIEVA 150MG

    Erlotinib Tablets IP 150mg

    ERLOLIEVA contains Erlotinib, an oral targeted anticancer medicine. It is a tyrosine kinase inhibitor (TKI) that selectively blocks the epidermal growth factor receptor (EGFR), thereby inhibiting tumor cell proliferation and survival—especially in EGFR-mutated cancers.

    View Details
    NINDALIEVA 150MG Nintedanib Softgelatin Capsules 150mg by NINDALIEVA 150MG

    NINDALIEVA 150MG

    Nintedanib Softgelatin Capsules 150mg

    NINDALIEVA contains Nintedanib, an oral tyrosine kinase inhibitor (TKI). It works by blocking multiple growth factor receptors (VEGFR, FGFR, PDGFR), inhibiting angiogenesis and tumor cell proliferation.

    View Details
    CRIZLIEVA 250MG Crizotinib Tablets 250mg by CRIZLIEVA 250MG

    CRIZLIEVA 250MG

    Crizotinib Tablets 250mg

    CRIZLIEVA 250 mg contains Crizotinib, an oral tyrosine kinase inhibitor (TKI). It targets ALK (anaplastic lymphoma kinase), ROS1, and MET receptors, inhibiting signaling pathways that drive tumor cell growth and survival. It is especially effective in ALK-positive and ROS1-positive lung cancers.

    View Details
    AFALIEVA 30MG Afatinib Tablets IP 30mg by AFALIEVA 30MG

    AFALIEVA 30MG

    Afatinib Tablets IP 30mg

    AFALIEVA 30 mg contains Afatinib, an oral irreversible ErbB family tyrosine kinase inhibitor (TKI). It covalently inhibits EGFR (ErbB1) and HER2 (ErbB2) receptors, blocking downstream signaling pathways involved in tumor cell growth and survival. It is effective in EGFR mutation–positive lung cancers.

    View Details
    AFALIEVA 40MG Afatinib Tablets IP 40mg by AFALIEVA 40MG

    AFALIEVA 40MG

    Afatinib Tablets IP 40mg

    AFALIEVA 40 mg contains Afatinib, an oral irreversible ErbB family tyrosine kinase inhibitor (TKI). It blocks EGFR (ErbB1) and HER2 (ErbB2) signaling by covalently binding to the receptor, thereby inhibiting tumor cell growth and survival. Afatinib is effective against tumors with EGFR activating mutations.

    View Details
    LENVALIEVA 10MG Lenvatinib Capsules 10mg by LENVALIEVA 10MG

    LENVALIEVA 10MG

    Lenvatinib Capsules 10mg

    LENVALIEVA 10 mg contains Lenvatinib, an oral multi-targeted tyrosine kinase inhibitor (TKI). It blocks receptors involved in tumor angiogenesis and growth, including VEGFR 1–3, FGFR 1–4, PDGFR-α, RET, and KIT, leading to inhibition of tumor blood vessel formation and cancer cell proliferation. 

    View Details
    ALIMLIEVA 500MG Pemetrexed Injection IP 500mg by ALIMLIEVA 500MG

    ALIMLIEVA 500MG

    Pemetrexed Injection IP 500mg

    ALIMLIEVA 500 mg contains Pemetrexed, a chemotherapy (anticancer) drug classified as a multitargeted antifolate antimetabolite. It inhibits key enzymes involved in purine and pyrimidine synthesis, leading to inhibition of DNA and RNA synthesis and cancer cell death. It is mainly used in non-squamous lung cancers.

    View Details
    ALIMLIEVA 100MG Pemetrexed Injection IP 100mg by ALIMLIEVA 100MG

    ALIMLIEVA 100MG

    Pemetrexed Injection IP 100mg

    ALIMLIEVA 100 mg contains Pemetrexed, a chemotherapy (anticancer) medicine classified as a multitargeted antifolate. It inhibits several enzymes involved in DNA and RNA synthesis, leading to suppression of cancer cell growth. It is mainly used in non-squamous lung cancers.

    View Details
    • 1

    24/7 Clients Support

    Best Price

    Quality Assurance